Hoth Therapeutics (HOTH) Q3 2023 Earnings

13NovConfirmed
Nov 22
Q4 2022
Q2 2023
Q3 2023
-2.39
-1.59
-0.8
0

Details

Expected EPS
-0.72
Actual EPS
-0.6
Surprise EPS
0.12
Surprise Percent
+16.67%

Description

Hoth Therapeutics (HOTH) has reported earnings of -0.6 per share for Q3 2023.

0 Comments

Share your thoughts